Navigation Links
St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing
Date:5/7/2008

A new study shows how sounds are amplified in the inner ear, a finding that could explain how hearing loss can result from genetic mutation or overdose of drugs

MEMPHIS, Tenn., May 7 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital investigators have found that an electrically powered amplification mechanism in the cochlea of the ear is critical to the acute hearing of humans and other mammals. The findings will enable better understanding of how hearing loss can result from malfunction of this amplification machinery due to genetic mutation or overdose of drugs such as aspirin.

Sound entering the cochlea is detected by the vibration of tiny, hair-like cilia that extend from cochlear hair cells. While the cochlea's "inner hair cells" are only passive detectors, the so-called "outer hair cells" amplify the sound signal as it transforms into an electrical signal that travels to the brain's auditory center. Without such amplification, hearing would be far less sensitive, since sound waves entering the cochlea are severely diminished as they pass through the inner ear fluid.

In their studies, Zuo and his colleagues have sought to establish the mechanism by which outer hair cells produce such amplification. Specifically, they wanted to distinguish between two amplification theories -- called "stereociliary motility" and "somatic motility" -- that have resulted from previous studies of the auditory machinery.

The stereociliary theory holds that amplification is produced by intricate vibrations of the bundles of cilia extending from the outer hair cells. The somatic motility theory proposes that the sound signal is amplified by an amplifier protein, called prestin, embedded in the hair cell membrane. Prestin is powered by voltages within the membrane that are produced by mechanical sound vibrations.

"This motility is also called 'dancing' because when you electrically stimulate an outer hair cell with a so
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Replikins LLC Finds West Nile Virus Replikin Count Has Reached Its Highest Recorded Value
2. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
3. Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
4. Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
5. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
6. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
7. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
8. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
9. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
10. St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases
11. Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v. 25 Praxis Electronic Medical Re...n Academy of Family Physicians, (AAFP) Family Prac...urvey for improving medical quality, health mainte...w ARRA Stimulus legislation. Praxis also ranked #1... effect in determining their salary. Finally, Prax...
(Date:11/25/2009)... Pharmasset, Inc. (Nasda...y committed to discovering, developing and commerc...ported financial results for the fiscal year ended...set held $58.4 million in cash, cash equivalents a... and 2009 Highlights ,, RG7128 ,, Phase...
(Date:11/25/2009)... The FDA granted traditional appro...n-nucleoside reverse transcriptase inhibitor (NNRT...ated for use in treatment-experienced adults who a...ns resistant to an NNRTI and other antiretroviral ...n 48-week data from two Phase 3 studies known as D...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Measuring intellectual disability 8977 1Measuring intellectual disability 8977 2M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 1M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers 8975 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 1BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 2BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 3BD Announces CE Marking of BD ProbeTec 26amp 3B 238482 3B Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 49844 4
...IEW, Calif., June 22, 2007 /PRNewswire/ -- MAP,Pha...esent Phase 2,data from its Unit Dose Budesonide (...the World Asthma Meeting at the Lutfi Kirdar,Conve... The oral and poster presentation entitled, "Effic...lation of budesonide for,nebulized delivery in a 6...
... Announces Bioinformatics Partnership with,Illumin...une 21, 2007,-GenoLogics, a leading developer of l... sciences research, today announced that,it has pe...technology partner and participant in IlluminaConn... by Illumina to advance,data integration and analy...
Other Medicine Technology:MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2GenoLogics Announces Bioinformatics Partnership with Illumina 2GenoLogics Announces Bioinformatics Partnership with Illumina 3
(Date:11/27/2009)... Biotech firm Replikins L...f the H1N1 virus genomic data. It shows that the ...f 3.7 (s.d. 4.5) during the virus,s current outbre...evels this week of 2.0 (s.d. 0.1). The H1N1 infect... Boston (PRWEB) November 27, 2009...
(Date:11/27/2009)..., , SAN FRANCISCO, Nov. 27 /PRNewswire-Firs...) announced that Blair Lambert, CFO/COO, will pres... will be held at the May Fair Hotel in London, Eng.... GMT. ,, To listen to a live broadcast of The ...net, please log on to www.gymboree.com, click on "...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /...merican professional cycling team dedicated to eth...f cycling champions, announced today that it will ...f Transitions Optical as a new sponsor of the team...acturer of adaptive eyewear, offering the most adv...
(Date:11/27/2009)... XenaCare Holdings has an...he Arthritis Foundation, one of the largest nonpro...and public health education. , ...- XenaCare Holdings, Inc. (OTCBB: XCHO), a company...tion of consumer healthcare products, has announce...
(Date:11/27/2009)...Soaring rates to bring unprecedented medical, econ... Nov. 27 (HealthDay News) -- The number of people ...double over the next 25 years, a new study predict...t 44.1 million people with the disease, up from 23... of treating people with diabetes will triple, the...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... Privatizing water supplies is only a pretext for ...precious resources of the people at large, activis...orldwide in the bottled water market, corporations...ontrols one-third of the U.S. market and sells 70 ...
... A revolutionary new imaging technology is expecte...s. Elasticity imaging is an ultrasound technique r... measure the stiffness of tissue, relative to surr...psies turn up positive for cancer. In a re...
... Loading a Super Soaker (a brand of recreational ...ight, worse ejaculating on stuffed animals, how de... are heard these days after a popular 17-year-old .... A week or so later, Mayor Tish Colombi and ...
... New tuberculosis (TB) vaccines in development hav...strains of TB, including multidrug-resistant (MDR)...rald C. Sadoff, president and CEO of the Aeras Glo... solely to creating new TB vaccines, is working to...
... Additional beneficial effects on cardiometabolic ...s in trials of the anti-obesity drug rimonabant ma...e in the June issue of Drug and Therapeutics Bulle...n cardiometabolic risk factors are beyond those ex...
... Tobacco is perhaps the most common addiction all .... Alarmed by the devastating impact of tob...ld Health Organization is calling for stringent re...1 crore, according to WHO estimates. The ...
Other Medicine News:Health News:Multinationals Exploit Groundwater Sources, and People Suffer 2Health News:Multinationals Exploit Groundwater Sources, and People Suffer 3Health News:Multinationals Exploit Groundwater Sources, and People Suffer 4Health News:Multinationals Exploit Groundwater Sources, and People Suffer 5Health News:Beer Bashes of Teens Spinning Out of Control in US 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 2Health News:New TB Vaccines in Could Protect Against All Drug Resistant Strains 3Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2Health News:Tobacco Menace and What can Be Done About It 2Health News:Tobacco Menace and What can Be Done About It 3Health News:Tobacco Menace and What can Be Done About It 4
Shahinian Lacrimal Cannula
Solo-Care Multipurpose Solution
Graether Collar Button On Handle
Graether Irrigating Collar Button
Medicine Products: